Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Technosphere Insulin versus subcutaneous prandial insulin in adults with type 1 diabetes
2006-000306-23Phase 3Completed
- Sponsor
- MannKind
- Start
- May 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Technosphere insulin, insulin glargine, insulin aspart and human insulin in diabetes mellitus type 1 (T1D) (2 arms), sponsored by MannKind. Primary endpoint: Change in HbA1c from baseline to Week 52. Started May 2006; status: completed.
02
Drugs
Technosphere insulininsulin glargineinsulin asparthuman insulin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2006-000306-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000306-23.